Platform|API|Archive|Contact

Humanexa SignalsPharmaceutical Intelligence

FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Pricing
Access
Commercial
Launch Tracking

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

Regulatory
Clinical
Competitive
Markets
M&A Watch
Strategy
Catalyst Tracker

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Company

pharma companies in neurology

Pharmaceutical intelligence for pharma companies in neurology with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Assets: 3

Recent signals(3)

ClinicalJuly 29, 2026

Web-based CBT for Insomnia in Dementia Caregivers: A New Study Launch

A new study is testing a web-based cognitive behavioral therapy for insomnia (WebCBT-I) tailored for dementia caregivers.

ClinicalJuly 7, 2026

Digital Biomarkers for Monitoring Limb Function in Inclusion Body Myositis

A study is validating digital biomarkers for monitoring upper limb function in Inclusion Body Myositis using wearable sensors.

CompetitiveJune 22, 2026

Study on Baiobit® Sensor Reliability for Gait Assessment in Stroke Survivors

A study evaluating the reliability of the Baiobit® inertial sensor for gait assessment in stroke survivors is underway.

Upcoming catalysts

No catalysts indexed for this entity yet.

Regulatory activity

No signals indexed for this entity yet.

Clinical activity(2)

ClinicalJuly 29, 2026

Web-based CBT for Insomnia in Dementia Caregivers: A New Study Launch

A new study is testing a web-based cognitive behavioral therapy for insomnia (WebCBT-I) tailored for dementia caregivers.

ClinicalJuly 7, 2026

Digital Biomarkers for Monitoring Limb Function in Inclusion Body Myositis

A study is validating digital biomarkers for monitoring upper limb function in Inclusion Body Myositis using wearable sensors.

Competitive activity(1)

CompetitiveJune 22, 2026

Study on Baiobit® Sensor Reliability for Gait Assessment in Stroke Survivors

A study evaluating the reliability of the Baiobit® inertial sensor for gait assessment in stroke survivors is underway.

Assets

Therapeutic areas

Dementia Care →

Inclusion Body Myositis →

Stroke Rehabilitation →

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.